Krystal Biotech, Inc. (KRYS) /
The cash flow of Krystal Biotech, Inc. over the past 10 years
Chart Krystal Biotech, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Krystal Biotech, Inc.'s operating cash flow was $200.87M and its capital expenditures $11.95M, leaving free cash flow of $188.91M. Free cash flow was above zero in 2 of the 10 years shown. It ranged from -$153.55M in fiscal 2022 to $188.91M in fiscal 2025. Capital expenditures were highest in fiscal 2021, at $68.34M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $200.87M | $11.95M | $188.91M |
| 2024ended Dec 31, 2024 | $123.42M | $4.24M | $119.18M |
| 2023ended Dec 31, 2023 | -$88.8M | $11.8M | -$100.6M |
| 2022ended Dec 31, 2022 | -$100.57M | $52.98M | -$153.55M |
| 2021ended Dec 31, 2021 | -$47.94M | $68.34M | -$116.27M |
| 2020ended Dec 31, 2020 | -$26.08M | $14.84M | -$40.93M |
| 2019ended Dec 31, 2019 | -$18.69M | $6.4M | -$25.09M |
| 2018ended Dec 31, 2018 | -$9.45M | $2.23M | -$11.68M |
| 2017ended Dec 31, 2017 | -$3.89M | $210K | -$4.1M |
| 2016ended Dec 31, 2016 | -$1.31M | $15K | -$1.33M |
Fiscal years as Krystal Biotech, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Krystal Biotech, Inc.
- The revenue of Krystal Biotech, Inc.
- The profitability of Krystal Biotech, Inc.
- The debt of Krystal Biotech, Inc.
- All of Krystal Biotech, Inc.'s financials, charted
Companies of a similar size
- ORIOLD REPUBLIC INTERNATIONAL CORPORATION
- LTHLife Time Group Holdings, Inc.
- TTEKTETRA TECH INC
- AURAurora Innovation, Inc.
- ATHMAutohome Inc.
Not investment advice. This page shows what Krystal Biotech, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.